Sanara MedTech Inc. ("Sanara" or the "Company") announced recent appointments. On May 28, 2018, the Board of Directors (the "Board") voted to (i) expand the size of the Board from three (3) to four (4) persons effective immediately (ii), elect J. Michael (Mike) Carmena as a Board member with the office of Vice Chairman and (iii) appoint Zachary (Zach) B. Fleming and Shawn M Bowman as new Company Officers. Additionally, the Company eliminated the role of Chief Executive Officer and appointed Mr. Carmena as the Principal Executive Officer.

As part of the strategic plan initiated by the Board, the Company will manage its operations in two separate divisions going forward: (1) the Surgical Division and (2) the Wound Care Division. Zachary B. Fleming has been appointed to the position of President, Surgical Division. Mr. Fleming joined the Company as Vice President of Sales in November 2017 and was promoted to Vice President, Surgical in September 2018.

Mr. Fleming successfully led the surgical sales organization to growth of approximately forty-percent in 2018 and remains responsible for the management of the expansion of the surgical sales force. Mr. Fleming has spent over thirteen years in the medical industry with Healthpoint Biotherapeutics, Smith &Nephew and Sanara MedTech. Mr. Fleming earned a Bachelor of Science from Indiana University.

Shawn M. Bowman has been appointed to the position of President, Wound Care Division and will lead the strategic expansion of the six previously discussed focus areas of wound care. Mr. Bowman previously served as the Company's Vice President and General Manager, Wound Care since September 2018. Mr. Bowman is a well-respected leader in chronic wound care with eighteen years of key experience in the medical device, biologics and pharmaceutical industries.

Prior to joining Sanara MedTech, Mr. Bowman built two successful teams as Senior Vice President of Wellsense, and as a National Sales Director for Smith &Nephew's Advanced Wound Management Division.